GENÈVE, 31 mai 2023 /PRNewswire/ — Les résultats à 12 mois de l’étude SELUTION SFA ont été présentés lors de la conférence Japan Endovascular Treatment (JET) à Tokyo. L’objectif de cette étude était d’évaluer la sécurité et l’efficacité de SELUTION SLR™, le nouveau ballon à élution de sirolimus de MedAlliance, pour le traitement endovasculaire des lésions … Read more
BOSTON, May 31, 2023 /PRNewswire/ — To enhance the patient experience throughout a clinical trial journey, Alcanza Clinical Research, a mission-driven investigator site network, announces a partnership with Climb, a provider of digital clinical trial solutions. Climb’s modular software connects every step of the participant journey from the point of initial outreach through study completion, … Read more
GENEBRA, 31 de maio de 2023 /PRNewswire/ — Os resultados de 12 meses do estudo SELUTION SFA foram apresentados na Japan Endovascular Treatment (JET) Conference, em Tóquio. O objetivo deste estudo foi o de avaliar a segurança e eficácia do SELUTION SLR™, um balão eluidor de sirolimus inovador da MedAlliance, para tratamento endovascular de lesões de-novo … Read more
GINEBRA, 31 de mayo de 2023 /PRNewswire/ — Los resultados de 12 meses del ensayo SELUTION SFA se presentaron en la Conferencia de Tratamiento Endovascular de Japón (JET) en Tokio. El objetivo de este estudio fue evaluar la seguridad y la eficacia de SELUTION SLR™, el novedoso balón liberador de sirolimus de MedAlliance, para el tratamiento … Read more
Study demonstrated promising results; planning underway to initiate Phase 2 trial in 2H 2023 CONCORD, Mass., May 31, 2023 /PRNewswire/ — Adiso Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines targeting chronic inflammatory diseases today announced the completion of a Phase 1b multiple ascending dose (MAD) clinical trial evaluating ADS051 (BT051) an oral, gut-restricted, … Read more
REHOVOT, Israel, May 31, 2023 /PRNewswire/ — Tissue Dynamics, a disruptive AI/ML biopharma company, announced today that Prof. Roger D. Kornberg, renowned biochemist and professor of structural biology at Stanford University, will be joining its advisory board. Prof. Kornberg, a Nobel laureate in chemistry for his work on the molecular mechanism of cellular transcription, as … Read more
Latest system installation in IceCure’s global commercial rollout of ProSense CAESAREA, Israel, May 31, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that ProSense was recently installed and inaugurated at … Read more
DSP107, a first-in-class CD47 and 4-1BB targeting fusion protein, in combination with atezolizumab, was well tolerated and demonstrated durable responses Dose was determined for Phase II expansion cohorts in 3rd line MSS-CRC and 2nd/3rd line NSCLC Data to be presented at ASCO 2023 MODI’IN, Israel, May 31, 2023 /PRNewswire/ — KAHR, a clinical-stage biotech company developing … Read more
NEW YORK, May 31, 2023 /PRNewswire/ — The global atopic dermatitis drugs market size is estimated to grow by USD 4,720.19 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 9.28%. North America will account for 36% of market growth during the forecast period. This growth is … Read more
MIAMI, May 31, 2023 /PRNewswire/ — Trawick International, an industry-leading international insurance company, today announced the appointment of Dr. Odemis Enriquez as Medical Director for its Latin America division, effective immediately. Dr. Enriquez joins Trawick International with vast experience in the medical and international insurance fields. She began her medical career in 1995 as an … Read more